What is the catalog number for Anti-Hu CD99 APC?

The catalog number for Anti-Hu CD99 APC is 1A-658-T100.

What sizes are available for Anti-Hu CD99 APC?

Anti-Hu CD99 APC is available in the following size(s): 100 Tests.

Is Anti-Hu CD99 APC in stock?

Anti-Hu CD99 APC is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Anti-Hu CD99 APC?

Anti-Hu CD99 APC is manufactured by AFG-XBO.

What is the estimated delivery time for Anti-Hu CD99 APC?

Estimated delivery time for Anti-Hu CD99 APC is approximately 10 business day(s), depending on your location.

Anti-Hu CD99 APC

CD99 is a ubiquitous transmembrane type I sialoglycoprotein of a unique and poorly characterized protein family. CD99 is heavily O-glycosylated and was described as a T cell costimulator and strong activator of integrin-mediated actin cytoskeleton assembly, promoting cell adhesion and homotypic aggregation, immediate arrest on an inflamed vascular endothelium, and cell migration through it. Ligation of CD99 under some conditions can lead to apoptosis. Originally CD99 was described as a human thymus leukemia antigen, an Ewing´s sarcoma-specific membrane marker, and an adhesion molecule involved in spontaneous rosette formation of T cells with erythrocytes.

Product Specifications

Certification

RUO

Reactivity

Human

Immunogen

Human thymocytes

Target Antigen

CD99

Clone

3B2/TA8

Applications

FC (QC tested)

Format

APC

Buffer

Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

References & Citations

*Kueng HJ, Leb VM, Haiderer D, Raposo G, Thery C, Derdak SV, Schmetterer KG, Neunkirchner A, Sillaber C, Seed B, Pickl WF: General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007 Aug;81 (16) :8666-76., URL: http://www.ncbi.nlm.nih.gov/pubmed/17537846 , *Pickl WF, Pimentel-Muiñ os FX, Seed B: Lipid rafts and pseudotyping. J Virol. 2001 Aug;75 (15) :7175-83., URL: http://www.ncbi.nlm.nih.gov/pubmed/11435598 , *Brémond A, Meynet O, Mahiddine K, Coito S, Tichet M, Scotlandi K, Breittmayer JP, Gounon P, Gleeson PA, Bernard A, Bernard G: Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction. Blood. 2009 Jan 8;113 (2) :347-57., URL: http://www.ncbi.nlm.nih.gov/pubmed/18849489 , *Waclavicek M, Majdic O, Stulnig T, Berger M, Sunder-Plassmann R, Zlabinger GJ, Baumruker T, Stöckl J, Ebner C, Knapp W, Pickl WF: CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol. 1998 Nov 1;161 (9) :4671-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/9794396, *Weijler L, Kowarsch F, Wödlinger M, Reiter M, Maurer-Granofszky M, Schumich A, Dworzak MN: UMAP based anomaly detection for minimal residual disease quantification within acute myeloid leukemia. Cancers (Basel) 2022 Feb 11;14 (4) :898., URL: https://pubmed.ncbi.nlm.nih.gov/35205645/

Storage Conditions

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Specificity

The mouse monoclonal antibody 3B2/TA8 recognizes an extracellular epitope of CD99, an approximately 32 kDa sialoglycoprotein expressed on the surface of many cell types, with particularly strong expression on Ewing´s sarcoma and peripheral primitive neuroectodermal tumors. Within the hematopoietic system, CD99 is expressed on virtually all cell types except granulocytes.